Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients

被引:90
|
作者
Duenne, A. A.
Mueller, H. H.
Eisele, D. W.
Kessel, K.
Moll, R.
Werner, J. A.
机构
[1] Univ Marburg, Dept Otolaryngol Head & Neck Surg, D-35037 Marburg, Germany
[2] Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany
[3] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA
[4] Univ Marburg, Inst Pathol, Marburg, Germany
关键词
perinodal spread; HNSCC; meta-analysis; survival; prognostic significance;
D O I
10.1016/j.ejca.2006.01.062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the risk factor of capsular rupture for individual prognosis and potential therapeutic decision making, the present meta-analysis elaborated the prognostic significance of perinodal spread in a large group of patients suffering from head and neck squamous cell carcinomas (HNSCC). A review of the published literature was conducted, and fixed and random effects models were applied for estimation of the summarised odds ratio and 95% confidence intervals, including a test for homogeneity of the odds ratios. Study methodology allowed the enrollment of only nine studies of 115 published papers. Excluded studies lacked regarding primary tumour location, number and location of lymph node metastases, values on five-year survival, or adequate follow-up data. A summarised odds ratio of 2.7 leads to the conclusion that perinodal spread negatively impacts the five-year survival. The lower confidence limit of more than 2 also supports the concept that perinodal spread significantly reduces (doubled risk) the five-year-survival. These results support the conclusion that perinodal spread is a significant adverse risk factor for survival in patients with HNSCC.
引用
收藏
页码:1863 / 1868
页数:6
相关论文
共 50 条
  • [21] A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications
    Chi, Li-Hsing
    Wu, Alexander T. H.
    Hsiao, Michael
    Li, Yu-Chuan
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [22] ANALYSIS OF PROGNOSTIC FACTORS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
    DREYFUSS, AI
    CLARK, JR
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (04) : 701 - 712
  • [23] Prognostic Significance of the Nodal Ratio and Number of Positive Nodes in Patients With Squamous Cell Carcinomas of the Head and Neck
    Reuter, Isabell
    Mueller, Hans-Helge
    Wiegand, Susanne
    ANTICANCER RESEARCH, 2022, 42 (11) : 5567 - 5570
  • [24] Prognostic impact of comorbidity in elderly patients with head and neck squamous cell carcinoma (HNSCC)
    Moreno Jimenez, M. A.
    Gonzalez Cebrian, I.
    Collado Martin, R.
    Medina Magan, B.
    Ortega Granados, A. L.
    Mateos Salido, M. J.
    Alonso Calderon, R.
    Plata, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [25] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis
    Wang, Yanting
    Li, Yuanyuan
    Jiang, Laibo
    Ren, Xianyue
    Cheng, Bin
    Xia, Juan
    AGING-US, 2021, 13 (05): : 7284 - 7299
  • [27] Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
    Dong, Yanbo
    Ma, Guangzhi
    Liu, Yukun
    Lu, Siyu
    Liu, Liangfa
    DISEASE MARKERS, 2020, 2020
  • [28] A systems immunology analysis to detect prognostic biomarkers in patients with squamous cell carcinomas of the head and neck
    Chester, Cariad
    Fernandez, Ajay
    Yonezawa, Atsushi
    Zhao, Xing
    Rajasekaran, Naren
    Kohrt, Holbrook
    CANCER RESEARCH, 2016, 76
  • [29] A study on prognostic factors for survival in patients with head and neck squamous cell carcinomas by multivariate analysis
    Sasaki, T
    Imai, Y
    Iwase, M
    Fujibayashi, T
    ORAL ONCOLOGY, VOL V, 1997, : 120 - 123
  • [30] Prognostic significance of performance status in patients with head and neck squamous cell carcinomas (HNSCC) receiving immune checkpoint monoclonal antibodies (ICmAB) in a single institution.
    Hwang, Victoria
    Martins, Renato G.
    Eaton, Keith D.
    Chow, Laura Quan Man
    Baik, Christina S.
    Goulart, Bernardo H. L.
    Lee, Sylvia Mina
    Santana-Davila, Rafael
    Rodriguez, Cristina P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35